Tysabri news is good for ISEQ
The ISEQ index climbed 121.78 points to 7894.62 this morning.
Elan soared €2.40 (21.2%) to €13.70 following news that multiple sclerosis drug Tysabri is expected to be approved to go back on sale shortly. It was the morning’s busiest share.
United Drug gained 3c to €3.83. It is due to publish its transition to International Financial Reporting Standards (IFRS) statement this day next week.
ISEQ 20 ETF shares were up 28c (1.8%) at €15.84.
CRH gained 31c (1.2%) to €26.90.
Allied Irish Bank was up 23c (1.2%) at €19.13, while Bank of Ireland gained 10c to €14.85.
Anglo Irish Bank was 10c in the black at €13.40. Irish Life and Permanent climbed 5c to €18.40.
Business support services company DCC slipped 20c (1%) to €19.20.
Ryanair fell 2c to €7.71, following its announcements of unchanged punctuality figures and a Cheltenham Festival giveaway.
